FDA panel recommends mRNA flu vaccine for older adults
A first-of-its-kind flu shot is a step closer to being available to the public after a Food and Drug Administration (FDA) advisory panel voted Thursday to recommend Moderna’s mRNA-based vaccine for approval. The FDA’s independent vaccine advisors voted unanimously 9-0 that the benefits outweigh the risks for Moderna’s mFlusiva shot in people ages 50 to 64 as well as 65 and older. Moderna is seeking…
100%
1 vote cast by the community
FLIC Trust Score100 / 100
How FLIC Trust Scores workFLIC Trust Scores turn community ratings into a 0–100 signal about how readers assess a story. Fake News votes lower the score, while Liberal, Conservative, and Independent classifications support it. The formula also rewards a balanced split between Liberal and Conservative ratings instead of treating one political viewpoint as automatically more trustworthy. Scores can change as more people vote and represent community judgment, not a factual verdict or substitute for reading the original reporting. Learn more about how FLIC works.